Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies

Corresponding Author

Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA

Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, Colorado, USA

Correspondence Xiao-Jing Wang, Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.

View original article

0 0 0 0 0 0 0

Comments (0)